RE: Wtf21 May 2024 22:45
"The Company will require further capital in order to execute its longer-term strategy which includes obtaining regulatory approval for new indications and the commercial launch of its technology in new jurisdictions, including Europe. The Board will therefore continue to explore additional funding options, including strategic partnerships, non-dilutive government funding from grants and further issues of Ordinary Shares, subject to the Directors being satisfied with the issue price of the shares at the time."
That bit is important also.